Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981168213> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W1981168213 endingPage "1573" @default.
- W1981168213 startingPage "1568" @default.
- W1981168213 abstract "Black American heart transplant recipients receiving cyclosporine-based primary immunoprophylaxis suffer higher rates of allograft rejection with hemodynamic compromise, infections, and posttransplant coronary artery disease. We examined the hypothesis that a combination of tacrolimus and mycophenolate mofetil resurrects clinical outcome of black Americans to those seen in white heart transplant recipients.Sixty-three adult primary heart transplant recipients were included in this study. Twenty black American and 21 white patients who received tacrolimus-based primary immunoprophylaxis were enrolled in this prospective, observational parallel cohort investigation. A separate group of 22 black American patients were randomly allocated to receive cyclosporine-microemulsion-based primary prophylaxis and served as the control population for assessing outcomes in the black American group. Adjunctive immunosuppression included mycophenolate mofetil and corticosteroids. The primary end-point was the freedom from allograft rejection requiring treatment at 1 year. Secondary end-points included rejection with hemodynamic compromise, and patient or graft survival. Adverse events evaluated included development of infections requiring hospitalization and nonimmunological outcomes including hyperlipidemia, hypertension, and diabetes mellitus (new onset or worsened).Tacrolimus-treated black American patients had greater freedom from allograft rejection requiring treatment at 1 year than those treated with cyclosporine (64% vs. 37%, P=0.01). No differences were noted between tacrolimus-treated black Americans and whites in the primary end point (64% and 67% respectively, P=nonsignificant [NS]). Tacrolimus-based immunosuppression was associated with better 1-year survival in black Americans compared with cyclosporine (95% vs. 73%, P=0.04), and this end point was similar to that achieved in tacrolimus-treated white heart transplant recipients (95%). No differences in infection rates were noted among either group. Cyclosporine-treated black Americans suffered more hyperlipidemia and worse hypertension than tacrolimus-treated patients.Compared with cyclosporine, an immunosuppressive strategy using tacrolimus in black Americans achieves superior efficacy with regard to allograft rejection, higher allograft survival, and similar safety. Furthermore, tacrolimus-based immunosuppression is similar in immunological efficacy and safety in black Americans and in white heart transplant recipients." @default.
- W1981168213 created "2016-06-24" @default.
- W1981168213 creator A5021169589 @default.
- W1981168213 creator A5037798286 @default.
- W1981168213 creator A5056960938 @default.
- W1981168213 creator A5087034704 @default.
- W1981168213 date "2002-12-01" @default.
- W1981168213 modified "2023-10-18" @default.
- W1981168213 title "Ethnic Disparity in clinical outcome after heart transplantation is abrogated using tacrolimus and mycophenolate mofetil-based immunosuppression" @default.
- W1981168213 cites W1907636864 @default.
- W1981168213 cites W1981264390 @default.
- W1981168213 cites W1998131880 @default.
- W1981168213 cites W2053133508 @default.
- W1981168213 cites W2069107011 @default.
- W1981168213 cites W2072623157 @default.
- W1981168213 cites W2123670789 @default.
- W1981168213 cites W2136905810 @default.
- W1981168213 cites W2146393124 @default.
- W1981168213 cites W2166931842 @default.
- W1981168213 doi "https://doi.org/10.1097/00007890-200212150-00014" @default.
- W1981168213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12490790" @default.
- W1981168213 hasPublicationYear "2002" @default.
- W1981168213 type Work @default.
- W1981168213 sameAs 1981168213 @default.
- W1981168213 citedByCount "52" @default.
- W1981168213 countsByYear W19811682132012 @default.
- W1981168213 countsByYear W19811682132013 @default.
- W1981168213 countsByYear W19811682132014 @default.
- W1981168213 countsByYear W19811682132015 @default.
- W1981168213 countsByYear W19811682132016 @default.
- W1981168213 countsByYear W19811682132018 @default.
- W1981168213 countsByYear W19811682132019 @default.
- W1981168213 countsByYear W19811682132021 @default.
- W1981168213 countsByYear W19811682132022 @default.
- W1981168213 crossrefType "journal-article" @default.
- W1981168213 hasAuthorship W1981168213A5021169589 @default.
- W1981168213 hasAuthorship W1981168213A5037798286 @default.
- W1981168213 hasAuthorship W1981168213A5056960938 @default.
- W1981168213 hasAuthorship W1981168213A5087034704 @default.
- W1981168213 hasBestOaLocation W19811682131 @default.
- W1981168213 hasConcept C126322002 @default.
- W1981168213 hasConcept C134018914 @default.
- W1981168213 hasConcept C141071460 @default.
- W1981168213 hasConcept C168563851 @default.
- W1981168213 hasConcept C203092338 @default.
- W1981168213 hasConcept C2778033501 @default.
- W1981168213 hasConcept C2778849806 @default.
- W1981168213 hasConcept C2780252810 @default.
- W1981168213 hasConcept C2908647359 @default.
- W1981168213 hasConcept C2909675724 @default.
- W1981168213 hasConcept C2911091166 @default.
- W1981168213 hasConcept C555293320 @default.
- W1981168213 hasConcept C71924100 @default.
- W1981168213 hasConcept C99454951 @default.
- W1981168213 hasConceptScore W1981168213C126322002 @default.
- W1981168213 hasConceptScore W1981168213C134018914 @default.
- W1981168213 hasConceptScore W1981168213C141071460 @default.
- W1981168213 hasConceptScore W1981168213C168563851 @default.
- W1981168213 hasConceptScore W1981168213C203092338 @default.
- W1981168213 hasConceptScore W1981168213C2778033501 @default.
- W1981168213 hasConceptScore W1981168213C2778849806 @default.
- W1981168213 hasConceptScore W1981168213C2780252810 @default.
- W1981168213 hasConceptScore W1981168213C2908647359 @default.
- W1981168213 hasConceptScore W1981168213C2909675724 @default.
- W1981168213 hasConceptScore W1981168213C2911091166 @default.
- W1981168213 hasConceptScore W1981168213C555293320 @default.
- W1981168213 hasConceptScore W1981168213C71924100 @default.
- W1981168213 hasConceptScore W1981168213C99454951 @default.
- W1981168213 hasIssue "11" @default.
- W1981168213 hasLocation W19811682131 @default.
- W1981168213 hasLocation W19811682132 @default.
- W1981168213 hasOpenAccess W1981168213 @default.
- W1981168213 hasPrimaryLocation W19811682131 @default.
- W1981168213 hasRelatedWork W1890838281 @default.
- W1981168213 hasRelatedWork W1982399324 @default.
- W1981168213 hasRelatedWork W1992117911 @default.
- W1981168213 hasRelatedWork W2011215652 @default.
- W1981168213 hasRelatedWork W2011454096 @default.
- W1981168213 hasRelatedWork W2011685216 @default.
- W1981168213 hasRelatedWork W2077727133 @default.
- W1981168213 hasRelatedWork W2113615533 @default.
- W1981168213 hasRelatedWork W2323967556 @default.
- W1981168213 hasRelatedWork W4200605501 @default.
- W1981168213 hasVolume "74" @default.
- W1981168213 isParatext "false" @default.
- W1981168213 isRetracted "false" @default.
- W1981168213 magId "1981168213" @default.
- W1981168213 workType "article" @default.